It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation
International Journal of Molecular Sciences · 23.06.2023 · 24 (13) · 10538
DOI: 10.3390/ijms241310538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.06.2023. Verfasst von Alessandra Murabito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center "Guido Tarone", University of Torino, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Telethon Foundation, European Cystic Fibrosis Society (ECFS) (Gerd Döring Award 2022, Cystic Fibrosis Europe (CF Europe) (ECFS/CF Europe Post-Doctoral Research Fellowship.
Abstract (Originalsprache)
Over the last fifteen years, with the approval of the first molecular treatments, a breakthrough era has begun for patients with cystic fibrosis (CF), the rare genetic disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). These molecules, known as CFTR modulators, have led to unprecedented improvements in the lung function and quality of life of most CF patients. However, the efficacy of these drugs is still suboptimal, and the clinical response is highly variable even among individuals bearing the same mutation. Furthermore, not all patients carrying rare CFTR mutations are eligible for CFTR modulator therapies, indicating the need for alternative and/or add-on therapeutic approaches. Because the second messenger 3′,5′-cyclic adenosine monophosphate (cAMP) represents the primary trigger for CFTR activation and a major regulator of different steps of the life cycle of the channel, there is growing interest in devising ways to fine-tune the cAMP signaling pathway for therapeutic purposes. This review article summarizes current knowledge regarding the role of cAMP signalosomes, i.e., multiprotein complexes bringing together key enzymes of the cAMP pathway, in the regulation of CFTR function, and discusses how modulating this signaling cascade could be leveraged for therapeutic intervention in CF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center "Guido Tarone", University of Torino, 10126 Torino, Italy.
- Kither Biotech S.r.l., 10126 Torino, Italy.
ORCID-Profile: Alessandra Murabito, Janki Bhatt, Alessandra Ghigo
Förderung
- Italian Telethon Foundation
- European Cystic Fibrosis Society (ECFS) (Gerd Döring Award 2022
- Cystic Fibrosis Europe (CF Europe) (ECFS/CF Europe Post-Doctoral Research Fellowship
- European Union’s Horizon 2020 research and innovation programme
Zitieren
APA
Murabito, A., Bhatt, J., & Ghigo, A. (2023). It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation. International Journal of Molecular Sciences, 24(13), 10538. https://doi.org/10.3390/ijms241310538
Vancouver
Murabito A, Bhatt J, Ghigo A. It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation. International Journal of Molecular Sciences. 2023;24(13):10538. doi:10.3390/ijms241310538
BibTeX
@article{Murabito2023,
author = {Murabito, Alessandra and Bhatt, Janki and Ghigo, Alessandra},
title = {It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {10538},
doi = {10.3390/ijms241310538}
}
EUVIMED